Establishing a Model for Assessing DNA Damage in Murine Brain Cells as a Molecular Marker of Chemotherapy-Associated Cognitive Impairment

Life Sciences - United States
doi 10.1016/j.lfs.2013.03.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy-Induced Cognitive Impairment

Clinical Cancer Research
Cancer ResearchOncology
2015English

Filamin-A as a Marker and Target for DNA Damage Based Cancer Therapy

DNA Repair
BiochemistryCell BiologyMolecular Biology
2012English

Frontal Atrophy as a Marker for Dementia Conversion in Parkinson's Disease With Mild Cognitive Impairment

Human Brain Mapping
Nuclear MedicineRadiologyUltrasound TechnologyAnatomyRadiologicalNeurologyImaging
2019English

An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal Study

Scientific Reports
Multidisciplinary
2019English

The Long Amplicon Quantitative PCR for DNA Damage Assay as a Sensitive Method of Assessing DNA Damage in the Environmental Model, Atlantic Killifish (Fundulus Heteroclitus)

Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology
Cell BiologyBiochemistryMedicineAnimal ScienceMutagenesisHealthAquatic ScienceZoologyToxicologyPhysiology
2009English

Brain Natriuretic Propeptide as a Marker of the Heart Damage in Metabolic Syndrome

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Erratum To: S100B as a Marker for Brain Damage and Blood–Brain Barrier Disruption Following Exercise

Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
2014English

Cognitive Change Questionnaire as a Method for Cognitive Impairment Screening

Dementia e Neuropsychologia
GerontologyGeriatricsNeurologySensory SystemsCognitive Neuroscience
2015English

Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment

Neural Plasticity
Neurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy